1FSY
AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CLOXACILLINBORONIC ACID
Summary for 1FSY
Entry DOI | 10.2210/pdb1fsy/pdb |
Related | 1C3B 1FSW 2BLS 3BLS |
Descriptor | CEPHALOSPORINASE, PHOSPHATE ION, N-[5-METHYL-3-O-TOLYL-ISOXAZOLE-4-CARBOXYLIC ACID AMIDE] BORONIC ACID, ... (4 entities in total) |
Functional Keywords | cephalosporinase, beta-lactamase, serine hydrolase, hydrolase |
Biological source | Escherichia coli |
Cellular location | Periplasm: P00811 |
Total number of polymer chains | 2 |
Total formula weight | 79745.71 |
Authors | Caselli, E.,Powers, R.A.,Blasczcak, L.C.,Wu, C.Y.,Prati, F.,Shoichet, B.K. (deposition date: 2000-09-11, release date: 2001-03-14, Last modification date: 2024-10-30) |
Primary citation | Caselli, E.,Powers, R.A.,Blasczcak, L.C.,Wu, C.Y.,Prati, F.,Shoichet, B.K. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases. Chem.Biol., 8:17-31, 2001 Cited by PubMed Abstract: Penicillins and cephalosporins are among the most widely used and successful antibiotics. The emergence of resistance to these beta-lactams, most often through bacterial expression of beta-lactamases, threatens public health. To understand how beta-lactamases recognize their substrates, it would be helpful to know their binding energies. Unfortunately, these have been difficult to measure because beta-lactams form covalent adducts with beta-lactamases. This has complicated functional analyses and inhibitor design. PubMed: 11182316DOI: 10.1016/S1074-5521(00)00052-1 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report